Robert Azelby, EVP & Chief Commercial Officer at Juno Therapeutics, Inc. (JUNO), sold 8,318 shares at $85.55 ($712K) on 2018-02-12, disclosed to the SEC on 2018-02-15.
Open-market sale of $712k JUNO by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.55 | 4,159 | $356K | 50.0% |
| 2 | $85.55 | 4,159 | $356K | 50.0% |
| Total | $85.55 avg | 8,318 | $712K | 100% |
| Filing → |
| JUNO | SELL | 2018-02-09 | $600K | — | Filing → |
| JUNO | SELL | 2018-02-02 | $715K | — | Filing → |
| JUNO | SELL | 2018-01-24 | $17.7M | — | Filing → |